Paper6540756
A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies.
Grotendorst CA and 3 others. Infect Immun, 1984. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies. Papers, record 6540756. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6540756
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Surface | Major topic |
| Malaria | Major topic |
| Plasmodium | Major topic |
| Aedes | |
| Animals | |
| Antibodies, Monoclonal | |
| Female | |
| Molecular Weight | |
| Proteins | |
| Zygote |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6683783 | Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. I. Zygote surface antigens. | Mol Biochem Parasitol | 1983 | https://conductscience.org/library/papers/6683783 | PubMed |
| 2 | 6350527 | Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum. | J Exp Med | 1983 | https://conductscience.org/library/papers/6350527 | PubMed |
| 3 | 6631012 | Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes. | J Immunol | 1983 | https://conductscience.org/library/papers/6631012 | PubMed |
| 4 | 6146930 | Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. II. Comparison of surface antigens of male and female gametes and zygotes. | Mol Biochem Parasitol | 1984 | https://conductscience.org/library/papers/6146930 | PubMed |
| 5 | 37101 | Plasmodium gallinaceum: exflagellation stimulated by a mosquito factor. | Exp Parasitol | 1979 | https://conductscience.org/library/papers/37101 | PubMed |
| 6 | 825377 | Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. | Eur J Immunol | 1976 | https://conductscience.org/library/papers/825377 | PubMed |
| 7 | 23512 | Gamete development in malaria parasites: bicarbonate-dependent stimulation by pH in vitro. | Parasitology | 1978 | https://conductscience.org/library/papers/23512 | PubMed |
| 8 | 437016 | Plasmodium gallinaceum: transmission-blocking immunity in chickens. I. Comparative immunogenicity of gametocyte- and gamete-containing preparations. | Exp Parasitol | 1979 | https://conductscience.org/library/papers/437016 | PubMed |
| 9 | 959832 | Successful immunization against the sexual stages of Plasmodium gallinaceum. | Science | 1976 | https://conductscience.org/library/papers/959832 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37896969 | Transmission-Blocking Vaccines for Canine Visceral Leishmaniasis: New Progress and Yet New Challenges. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37896969 | PubMed |
| 37499679 | Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial. | Lancet Infect Dis | 2023 | https://conductscience.org/library/papers/37499679 | PubMed |
| 36527077 | Genetic diversity of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax isolates from China. | BMC Infect Dis | 2022 | https://conductscience.org/library/papers/36527077 | PubMed |
| 35895392 | Efforts to Develop Pfs25 Vaccines. | Am J Trop Med Hyg | 2022 | https://conductscience.org/library/papers/35895392 | PubMed |
| 35895377 | On Malaria Transmission and Transmission Blocking Immunity. | Am J Trop Med Hyg | 2022 | https://conductscience.org/library/papers/35895377 | PubMed |
| 34301597 | A malaria parasite phospholipid flippase safeguards midgut traversal of ookinetes for mosquito transmission. | Sci Adv | 2021 | https://conductscience.org/library/papers/34301597 | PubMed |
| 33737844 | Towards Eradication of Malaria: Is the WHO's RTS,S/AS01 Vaccination Effective Enough? | Risk Manag Healthc Policy | 2021 | https://conductscience.org/library/papers/33737844 | PubMed |
| 33561016 | Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice. | J Clin Invest | 2021 | https://conductscience.org/library/papers/33561016 | PubMed |
| 32566259 | Malaria vaccines since 2000: progress, priorities, products. | NPJ Vaccines | 2020 | https://conductscience.org/library/papers/32566259 | PubMed |
| 32450861 | Purification and production of Plasmodium falciparum zygotes from in vitro culture using magnetic column and Percoll density gradient. | Malar J | 2020 | https://conductscience.org/library/papers/32450861 | PubMed |
| 32273496 | An intracellular membrane protein GEP1 regulates xanthurenic acid induced gametogenesis of malaria parasites. | Nat Commun | 2020 | https://conductscience.org/library/papers/32273496 | PubMed |
| 31566026 | Malaria transmission-blocking vaccines: wheat germ cell-free technology can accelerate vaccine development. | Expert Rev Vaccines | 2019 | https://conductscience.org/library/papers/31566026 | PubMed |
| 30061051 | Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults. | Lancet Infect Dis | 2018 | https://conductscience.org/library/papers/30061051 | PubMed |
| 25775466 | Recombinant Pvs48/45 antigen expressed in E. coli generates antibodies that block malaria transmission in Anopheles albimanus mosquitoes. | PLoS One | 2015 | https://conductscience.org/library/papers/25775466 | PubMed |
| 19091043 | Plasmodium vivax: who cares? | Malar J | 2008 | https://conductscience.org/library/papers/19091043 | PubMed |
| 15733320 | Do malaria ookinete surface proteins P25 and P28 mediate parasite entry into mosquito midgut epithelial cells? | Malar J | 2005 | https://conductscience.org/library/papers/15733320 | PubMed |
| 9673236 | Mapping of specific and promiscuous HLA-DR-restricted T-cell epitopes on the Plasmodium falciparum 27-kilodalton sexual stage-specific antigen. | Infect Immun | 1998 | https://conductscience.org/library/papers/9673236 | PubMed |
| 9169761 | Two antigens on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei that are distinct targets of transmission-blocking immunity. | Infect Immun | 1997 | https://conductscience.org/library/papers/9169761 | PubMed |
| 8506371 | Transfection of the malaria parasite and expression of firefly luciferase. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8506371 | PubMed |
| 8426118 | Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies. | J Exp Med | 1993 | https://conductscience.org/library/papers/8426118 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6540756
GET https://conductscience.org/api/papers/v1/6540756/cited_by?page=2